Cargando…

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours

BACKGROUND: Neuroblastoma is a paediatric tumour originated from sympathoadrenal precursors and characterized by its heterogeneity and poor outcome in advanced stages. Intra-tumoral cellular heterogeneity has emerged as an important feature in neuroblastoma, with a potential major impact on tumour a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vega, Francisco M., Colmenero-Repiso, Ana, Gómez-Muñoz, María A., Rodríguez-Prieto, Ismael, Aguilar-Morante, Diana, Ramírez, Gema, Márquez, Catalina, Cabello, Rosa, Pardal, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945283/ https://www.ncbi.nlm.nih.gov/pubmed/31685444 http://dx.doi.org/10.1016/j.ebiom.2019.10.041

Ejemplares similares

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”
por: Vega, Francisco M., et al.
Publicado: (2020)

Neural crest derived progenitor cells contribute to tumor stroma and aggressiveness in stage 4/M neuroblastoma
por: Linares-Clemente, Pedro, et al.
Publicado: (2017)

Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness
por: Gómez-Muñoz, María A., et al.
Publicado: (2023)

Hypoxia in the Initiation and Progression of Neuroblastoma Tumours
por: Huertas-Castaño, Carlos, et al.
Publicado: (2019)

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation
por: Colmenero-Repiso, Ana, et al.
Publicado: (2020)

A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines
por: Amador-Álvarez, Aida, et al.
Publicado: (2022)

Physiological Plasticity of Neural-Crest-Derived Stem Cells in the Adult Mammalian Carotid Body
por: Annese, Valentina, et al.
Publicado: (2017)

The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
por: Mus, Liselot M., et al.
Publicado: (2020)

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
por: Esteban, F., et al.
Publicado: (1990)

The ‘Unicorn’ Dinosaur That Wasn’t: A New Reconstruction of the Crest of Tsintaosaurus and the Early Evolution of the Lambeosaurine Crest and Rostrum
por: Prieto-Márquez, Albert, et al.
Publicado: (2013)

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness
por: Molleví, D G, et al.
Publicado: (2008)

Tumour Endoprosthetic Reconstruction for Primary Aggressive and Malignant Bone Tumours of the Distal Femur
por: Rubio, DA, et al.
Publicado: (2013)

Pleural solitary fibrous tumour with brain metastasis: an aggressive tumour and pathologic conundrum
por: Williams, Catherine, et al.
Publicado: (2022)

High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
por: Hamano, R, et al.
Publicado: (2012)

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes
por: Thorell, Kaisa, et al.
Publicado: (2009)

MYCN induces neuroblastoma in primary neural crest cells
por: Olsen, R R, et al.
Publicado: (2017)

Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
por: Johnsen, John Inge, et al.
Publicado: (2019)

Aggressive surgical palliation for advanced girdle tumours
por: Burd, Andrew, et al.
Publicado: (2012)

Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours
por: van Sprundel, Renee GHM, et al.
Publicado: (2010)

Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
por: Ito, Toshiki, et al.
Publicado: (2019)

Intra-Tumour Genetic Heterogeneity and Prognosis in High-Risk Neuroblastoma
por: López-Carrasco, Amparo, et al.
Publicado: (2021)

Adenomatoid paratesticular tumour – Rare presentation in a child
por: Morgado, Mariana, et al.
Publicado: (2018)

Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
por: Avgustinova, Alexandra, et al.
Publicado: (2016)

Pazopanib is an active treatment in desmoid tumour/aggressive fibromatosis
por: Martin-Liberal, Juan, et al.
Publicado: (2013)

RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes
por: Khan, Faizan H., et al.
Publicado: (2015)

Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.
por: EjeskÃ¤r, K., et al.
Publicado: (1998)

Interspecific Aggressions between Crested Porcupines and Roe Deer
por: Lazzeri, Lorenzo, et al.
Publicado: (2020)

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.
por: Christiansen, H., et al.
Publicado: (1988)

Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
por: Bjellerup, P, et al.
Publicado: (2000)

Epidemiological evidence for a common mechanism for neuroblastoma and differentiated thyroid tumour.
por: de Vathaire, F., et al.
Publicado: (1992)

Collaboration of cancer‐associated fibroblasts and tumour‐associated macrophages for neuroblastoma development
por: Hashimoto, Okito, et al.
Publicado: (2016)

Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
por: Yang, Daheng, et al.
Publicado: (2021)

Neuroblastoma Interaction with the Tumour Microenvironment and Its Implications for Treatment and Disease Progression
por: Jahangiri, Leila
Publicado: (2023)

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
por: Patard, J-J, et al.
Publicado: (2009)

ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells
por: Gonzalez Malagon, Sandra G, et al.
Publicado: (2018)

Desmoid Tumours of the extremity and trunk. A retrospective study of 44 patients
por: Wirth, Laura, et al.
Publicado: (2018)

Functional analysis of CD44 variants and xCT in canine tumours
por: Tanabe, Atsushi, et al.
Publicado: (2020)

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?
por: Sigal-Zafrani, B, et al.
Publicado: (2007)

Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour)
por: Hong, H, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_17l8k8bbq3l9skofge8uljggj5